Article · 2 Jun 2026
Conference abstract
High MACC1 expression in combination with mutated KRAS G13 indicates poor survival of colorectal cancer patients
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Colorectal cancer (CRC) is the third most common cancer worldwide. The metastasis-associated in colon cancer 1 (MACC1) gene has been identified as prognostic biomarker for CRC. Here, we aimed at the refinement of risk assessment by separate and combined survival analyses of MACC1 expression with any of the markers KRAS mutated in codon 12 (KRAS G12) or codon 13 (KRAS G13), BRAFV600 mutation and MSI status in a retrospective study of 99 CRC patients with tumors staged I, II and III. Our results showed that high MACC1 expression (HR: 6.09, 95% CI: 2.50-14.85, P<0.001) and KRAS G13 mutation (HR: 5.19, 95% CI: 1.06-25.45, P=0.042) were the only independent prognostic markers for shorter metastasis-free survival (MFS). Accordingly, Cox regression analysis revealed that patients with high MACC1 expression and KRAS G13 mutation exhibited the worst prognosis (HR: 14.48, 95% CI: 3.37-62.18, P<0.001). By integrative 2-step cluster analysis the patient cohort was classified into four clusters with statistically different MFS (P=0.003) which coincided well with the different CRC pathways. According to our results, patients of the group with mutated KRAS G13 and high MACC1 expression exhibited the highest risk for metachronous metastasis formation. Moreover, we demonstrated that the “traditional pathway” with an intermediate risk for metastasis formation can be further subdivided by assessing MACC1 expression into a low and high risk group with regard to MFS prognosis. The identification of CRC patients at high risk for metastasis is possible by assessing MACC1 expression in combination with KRAS G13 mutation.
Keywords
Subjects
Genetics & Molecular BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Stem Cell Research & Therapy.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Stem Cell Research & Therapy
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “Katharina Ilm”
- BylineArticles whose byline prints “Wolfgang Kemmner”
- BylineArticles whose byline prints “Marc Osterl”
- BylineArticles whose byline prints “Susen Burock”
- BylineArticles whose byline prints “Gudrun Koch”
- BylineArticles whose byline prints “Pia Herrmann”
- BylineArticles whose byline prints “Peter M Schlag”
- BylineArticles whose byline prints “Ulrike Stein”
